GLYCEMIC BEHAVIOR IN 48 HOURS POSTOPERATIVE PERIOD OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND NON DIABETIC SUBMITTED TO BARIATRIC SURGERY

Lucas Freitas de Oliveira, Caroline Gewehr Tisott, Diego Machado Silvano, Camila Mafalda Mouta Campos, Ricardo Reis do Nascimento, Lucas Freitas de Oliveira, Caroline Gewehr Tisott, Diego Machado Silvano, Camila Mafalda Mouta Campos, Ricardo Reis do Nascimento

Abstract

Although there is no indication for surgery taking only into account the glycemic condition, results have shown that benefits can be obtained in glycemic control with bariatric surgery.

Aim: To compare the glycemic behavior among type 2 diabetic and non-diabetic patients within 48 h after bariatric surgery, and clarify whether there is a reduction in blood glucose level in obese patients with diabetes before the loss of weight excess.

Methods: Descriptive epidemiological study with prospective cohort design with 31 obese patients undergoing Roux-en-Y gastric bypass and sleeve gastrectomy. The patients were controlled with hemoglucotests in different periods of time: preoperative, postoperative and each 6 h after surgery for 48 h.

Results: Average ambulatory blood glucose in diabetics was 120.7±2.9 mg/dl vs 91.8±13.9 mg/dl in the nondiabetic. After 48 h there was decrease in diabetics to 100.0±17.0 mg/dl (p=0.003), while the non-diabetic group did not change significantly (102.7±25.4 mg/dl; p=0.097). There were no differences between the surgical techniques. There were no death.

Conclusions: Diabetic patients significantly reduced blood glucose after surgery regardless of the use of exogenous insulin or oral hypoglycemic agents.

Conflict of interest statement

Conflicts of interest: none

References

    1. Alves A, Freire R, Alves MR, Barreto JA. Impacto da cirurgia bariátrica nos níveis de IGF-1, glicemia, insulina e resistência à insulina em pacientes obesos mórbidos. Bariátrica & Metabólica Íbero Americana. 2011;1:164–173.
    1. American Diabetes Association Economic Costs of Diabetes in the U.S in 2012. Diabetes Care. 2013;36:1033–1046.
    1. Ayoub JAS, Alonso PA, Guimarães LMV. Efeitos da cirurgia bariátrica sobre a syndrome metabolica. ABCD Arq Bras Cir Dig. 2011;24(2):140–143.
    1. Blaire A, Switzer NJ, Almamar A, Shi X. The impact of laparoscopic sleeve gastrectomy on plasma ghrelin levels: a systematic review. Obes Surg. 2013;23:1476–1480.
    1. Bunchwald H, Varco RL. Metabolic Surgery.New York, NY: Grune & Stratton; 1978.
    1. Carlsson LMS, Peltonen M, Ahlin S, Anveden A. Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects. N Engl J Med. 2012;367:695–704.
    1. Cohen R, Torres M, Schiavon C. Cirurgia metabolic: mudanças na anatomia gastrointestinal e remissão do diabetes mellitus tipo 2. ABCD Arq Bras Cir Dig. 2010;23(1):40–45.
    1. Colguit J, Clegg A, Loveman E, Royle P, Sidhu MK. Surgery for morbid obesity. Cochrane Database Syst Rev. 2009;(2):CD003641–CD003641.
    1. Dirksen C, Jørgensen NB, Bojsen-Møller KN, Jacobsen SH et al Mechanisms of improved glycaemic control after Roux-em-Y gastric bypass. Diabetologia. 2012;55:1890–1901.
    1. Evans S, Pamuklar Z, Rosko J, Mahaney P. Gastric bypass restores meal stimulation of the anorexigenic gut hormones glucagon-like, peptide-1 and peptide YY independent of caloric restriction. Surg Endosc. 2012;26(4):1086–1094.
    1. Flancbaum L, Belsley S. Factors affecting morbidity and mortality of Roux-em-Y gastric bypass for clinically severe obesity: an analisys of 1.000 consecutive open cases by a single surgeon. J Gastrointest Surg. 2007;11:500–507.
    1. Guedes AA. A importância do controle glicêmico perioperatório. Rev Med Minas Gerais. 2010;20(4):3–6.
    1. Holdstock C, Zethelius B, Sundbom M, Karlsson FA. Postprandial changes in gut regulatory peptides in gastric bypass patients. Int J Obes. 2008;32:1640–1646.
    1. Le Roux CW, Aylwin SJ, Batterham RL, Borg CM. Gut hormone profiles following bariatric surgery favor na anorectic state, facilitate weight loss and improve metabolic parameters. Ann Surg. 2006;243:108–114.
    1. Le Roux CW, Welbourn R, Werling M, Osborne A. Gut hormone as mediators of appetite and weight loss after Roux-em-Y gastric bypass. Ann Surg. 2007;246(5):780–785.
    1. Lipshutz AKM, Gropper MA. Perioperative glycemic control: an evidence based review. Anesthesiology. 2009;5:408–421.
    1. Maggard MA, Shugarman LR, Suttorp M, Maglione M. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142(7):547–559.
    1. Ministério da Saúde . Vigitel Brasil 2011: Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico. Ministério da Saúde, Secretaria de Vigilância em Saúde - Brasília: Ministério da Saúde; 2012.
    1. Pedrosa IV, Burgos MGPA, Souza NC, Morais CN. Aspectos nutricionais em obesos antes e após a cirurgia bariátrica. Rev Col Bras Cir. 2009;36(4):316–322.
    1. Plum L, Ahmed L, Febres G, Bressler M. Comparison of glucostatic parameters after hypocaloric diet or bariatric surgery and equivalent weight loss. Obesity. 2011;19(11):2149–2157.
    1. Pories WJ, Swanson MS, MacDonald KG, Long SB. Who would have thought it? An operation proves to be the most effective therapy for adult-onset Diabetes Mellitus. Ann Surg. 1995;222(3):339–352.
    1. Schauer PR, Kashyap SR, Wolski K, Brethauer AS. Bariatric Surgery versus Intesive Medical Therapy in Obese Patientes with Diabetes. N Engl J Med. 2012;366:1567–1576.
    1. Scopinaro N. Bariatric metabolic surgery. Rozhl Chir. 2014;93:404–415.
    1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice. 2010;87:4–14.
    1. Teixeira TGAB. Cirurgia Metabólica no diabete mellitus tipo 2: eficácia de diferentes procedimentos cirúrgicos e comparação de pacientes com IMC ≥ e < 35 kg/m2. Covilhã: Universidade da Beira Interior; 2012.
    1. World Health Organ Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854:1–452.
    1. World Health Organization . Obesity. 2011.
    1. World Health Organization . The World Health Report - Reducing risks, promoting healthy lifes. World Health Organization; 2002.
    1. Zeve JLM, Tomaz CAB. Cirurgia Metabólica - Cura para Diabete Melito tipo 2. ABCD Arq Bras Cir Dig. 2011;24(4):312–317.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner